CorMedix (CRMD) Non Operating Income (2011 - 2025)

CorMedix has disclosed Non Operating Income across 12 years of filings, most recently posting -$2.7 million for Q4 2025.

• Non Operating Income for Q4 2025 came in at -$2.7 million, down 9.55% year-over-year; the trailing twelve-month figure through Dec 2025 was -$124999.0 (down 319.29% YoY), and the FY2025 annual result was -$125000.0, down 319.3% from the prior year.
• Non Operating Income came in at -$2.7 million for Q4 2025 at CorMedix, down from $1.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $1.2 million in Q3 2025 to a low of -$2.7 million in Q4 2025.
• The 5-year median for Non Operating Income is $315115.0 (2022), against an average of $143219.2.
• Across the five-year window, Non Operating Income plunged 379.88% in 2021 and jumped 24647.35% in 2023, its largest moves.
• CorMedix's Non Operating Income stood at -$11066.0 in 2021, then soared by 1729.11% to $180277.0 in 2022, then jumped by 407.39% to $914715.0 in 2023, then tumbled by 367.43% to -$2.4 million in 2024, then retreated by 9.55% to -$2.7 million in 2025.
• The last three Non Operating Income figures came in at -$2.7 million (Q4 2025), $1.2 million (Q3 2025), and $805983.0 (Q2 2025), per Business Quant data.